These data indicate that factors present in the tumor microenvironment like TGF-beta and low IL-2, can induce IL-9 in TILs from patients with NSCLC and simultaneously induce Foxp3+ T regulatory cells. This evidence concerns the gene FOXP3 and non-small cell lung carcinoma.